CARDIOVASCULAR DISEASE PREVENTION INFOGRAPHIC RUSHCLIFFE CCG CVD PREMATURE ATRIAL BLOOD CHRONIC HEART MORTALITY FIBRILLATION PRESSURE KIDNEY DISEASE FAILURE DIABETES

CVD PREMATURE MORTALITY STROKE ADMISSIONS WITH NUMBER OF PEOPLE WITH NUMBER OF PEOPLE WITH HEART FAILURE PATIENTS S PREVALE E NC ET E UNDIAGNOSED HYPERTENSION B I KNOWN AF 2014-15 UNDIAGNOSED CKD WITH LVSD A N I L D A N S I March T E 5 S

2014 Y 178 A E

E A

March R

R C

22.5% S

13,818 353 2015 N I

376

CCG Range

38 HEART FAILURE ADMISSIONS 9.2% to 26.0%

(25.7%) 55% 95% 20 Admissions 2013-14 2014-15 10 -15 observed to expected observed to expected -11 to 2014 HYPERTENSION PREVALENCE CKD PREVALENCE Primary Diagnosis# 132 170

Actual = 14.0% Actual = 6.5% Secondary Diagnosis 591 672 Practice Participation in NUMBER OF Estimated = 92% National Diabetes Audit 25.2% Estimated = 7.3% Admission Costs 2013-14 2014-15 2014-15

UNDIAGNOSED Primary Diagnosis# £420,000 £589,000 AF PATIENTS... 2,640 1,495 CARE CVD PREMATURE Secondary Diagnosis £1,820,000 £2,065,000 Hypertensive patients with BP CKD patients with BP PROCESSES MORTALITY RATE 2009-2014 Admission Rate per 2014-15 2014-15 E.Mids Av NOT TO QOF target 150/90 NOT TO QOF target 140/85 1000 HF Patients (15.3%) Primary Diagnosis# 179 179 TYPE 1 - 42.2% (23.3%) = 39.6% 2009 % observed to expected *includes exception reported *includes exception reported E.Mids CCG Range = 29.3 - 54.0% 80.3 Secondary Diagnosis 707 749 Lowest 8 Care Process AF prevalence 64.5% Urine Albumin 2010 90.8 FAMILIAL TYPE 2 - 70.5% 2011 79.7 152 Heart Failure England = 59.0% HYPERCHOLESTEROLEMIA (FH) E.Mids CCG Range = 51.2 - 73.8% LVSD patients NOT on Lowest 8 Care Process 2012 69.3 dual therapy 83.9% Urine Albumin Estimated people with FH 2013 74.2 HEART ATTACKS IN PEOPLE ACE inhibitor/ARB and UNDER 50 - 2012-13 to 2014/15 a betablocker (40.4%) % OF DIABETIC PATIENTS 2014 67.2 378 247 - 494 High risk AF patients Rate = 1 per 500 Rate = 1 per 250 MEETING 3 TARGETS 2014-15 NOT on anticoagulation DIABETIC NUMBER OF PREMATURE 47 Estimated 15% diagnosed with FH DEATHS DUE TO CVD IN 2014 (30.1%) FOOT AMPUTATIONS TYPE 1 - 21.7% England = 19.3% *includes exception reported 37 74 E.Mids CCG Range = 14.6 - 28.5% Rate = 1 per 500 - Rate = 1 per 250 APRIL 2010 - MARCH 2013 Rate per 1000 diabetic CCG EXCEPTION REPORTING FOR Number patients ANTICOAGULATION Total 34 2.43 BLOOD 45 PRESSURE LEADING CAUSES OF YEARS SMOKING DATA BY LOCAL AUTHORITY Major 10 0.71 OF LIFE LOST IN ENGLAND Smoking prevalence in adults in Successful quitters at 4 HbA1C 18.5% Smoking Prevalence in adults - routine and manual occupations - weeks per 100,000 smokers GLOBAL BURDEN OF DISEASE STUDY 2013 Minor 24 1.71 PRACTICE RANGE OF Local Authority current smokers (2014) current smokers (2014) (2014-15) EXCEPTION REPORTING 18.7 33.1 1,351 19.9 31.5 1,559 APRIL 2011 - MARCH 2014 Rate per 20.7 28.9 3,214 1000 diabetic Number patients CHOLESTEROL 17.0 28.9 3,052 14.1 29.6 2,456 Total 34 2.29 4.1% - 17.5 25.6 3,567 19.3 32.0 2,396 Major 9 0.61 TYPE 2 - 41.8% England = 41.3% 24.2 28.1 2,804 Minor 25 1.68 E.Mids CCG Range = 35.6 - 44.6% 23.8% 17.5 27.8 3,256 East 18.8 29.2 2,727 Rate in 2011 - 2014 Produced by: Better Similar Worse Compared to England average Total - 2.37 Major - 0.82 Minor - 1.55